Novasep is a France-based life sciences company that provides contract development and manufacturing services (CDMO) and process technologies for the pharmaceutical and biotechnology industries. The company focuses on the development and cGMP production of complex small‑molecule active pharmaceutical ingredients (APIs) and intermediates, including highly potent APIs, and offers purification solutions for biopharmaceuticals.
Its core competencies include chromatography and other downstream purification technologies, continuous and batch processing, and specialized chemistries such as those used for antibody–drug conjugates (ADCs). Novasep also designs and supplies purification and chromatography equipment and supports projects from early development through commercial scale. It serves global pharmaceutical, biotech, and fine chemicals customers through a network of facilities in Europe and other regions.
